Last viewed: AZN

Prices are updated after-hours

AZN Nasdaq 2020 - 11 - 09

Astrazeneca PLC

AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

(0.0% 1d) (3.6% 1m) (-9.3% 1y) (0.0% 2d) (0.0% 3d) (-0.3% 7d) (-11.68% volume)
Earnings Calendar:
Market Cap: $ 212,566,343,011
http://astrazeneca.com
Sec Filling | Patents | 70600 employees

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

cardiovascular respiratory urea renal metabolic

add to watch list Paper trade email alert is off

Press-releases

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| 0.66% | O: 0.24% H: 0.42% C: 0.42%
NVO | News | $122.71 -0.03% 0.17% 5M

|

Health Technology

| -1.46% | O: -0.84% H: 0.86% C: -0.62%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| 0.38% | O: -0.58% H: 0.99% C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M

|

Health Technology

| -3.26% | O: -0.21% H: 0.11% C: -3.05%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 0.42% | O: -0.18% H: 0.84% C: 0.6%
report reach therapeutics market

Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| -0.26% | O: -0.64% H: 0.45% C: -0.04%
million series trials program

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| 0.19% | O: 2.1% H: 0.0% C: -2.52%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| 0.17% | O: -1.46% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -1.85% | O: -1.19% H: 0.52% C: -0.17%
BAX | $39.47 -0.45% 0.0% 2.8M

|

Health Technology

| -1.42% | O: -0.1% H: 0.13% C: -1.08%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| 2.93% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -1.22% | O: -2.13% H: 0.0% C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M

|

Health Technology

| -3.15% | O: -0.72% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| -0.26% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| 1.29% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| -0.04% | O: 1.47% H: 1.16% C: -1.27%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 1.38% | O: 3.34% H: 0.27% C: -0.62%
children approved treatment for

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| 2.24% | O: -3.43% H: 6.21% C: 6.21%
VTRS A | $11.25 1.17% 1.16% 4.7M

|

Health Technology

| -4.66% | O: -0.25% H: 1.1% C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.49% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.93 1.3% 0.0% 10M

|

Health Technology

| -4.66% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.69 1.05% 0.0% 2.9M

|

Health Technology

| -16.52% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| -0.9% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -1.33% | O: 0.84% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 1.63% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in genome editing boost the market- Technavio
Published: 2024-04-05 (Crawled : 22:00) - prnewswire.com
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| Email alert Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M

|

Health Technology

| Email alert Add to watchlist
CRBU | $3.87 -1.02% -1.03% 1.7M

|

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| Email alert Add to watchlist
set market

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 0.88% | O: -1.18% H: 0.34% C: -0.22%
breast her2 license cancer application negative

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| Email alert Add to watchlist
CKPT | $1.47 -8.13% -8.84% 760K

|

Health Technology

| Email alert Add to watchlist
FBIO | $1.765 -2.49% -2.55% 190K

|

Health Technology

| Email alert Add to watchlist
MBIO | $0.3451 -6.98% -7.51% 130K

|

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| Email alert Add to watchlist
DERM | $3.45 -3.63% -3.77% 100K

|

| Email alert Add to watchlist
biotech financial results

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

|

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| 1.11% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $94.36 1.93% 0.0% 2.3M

|

Health Technology

| -1.59% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

|

Health Technology

| -7.54% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.93 1.3% 0.0% 10M

|

Health Technology

| -8.11% | O: 0.26% H: 2.03% C: 1.57%
ABBV | $166.41 1.06% 0.0% 5.5M

|

Health Technology

| -7.73% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $107.28 1.91% 0.18% 10M

|

Health Technology

| -4.27% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

|

Health Technology

| -6.88% | O: -0.96% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 0.42% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $269.03 2.39% 2.33% 3.4M

|

Health Technology

| -6.07% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800

|

Health Technology

| 2.89% | O: 0.75% H: 0.04% C: -0.1%
AZN | News | $68.56 0.29% 0.29% 4.7M

|

Health Technology

| 3.46% | O: -0.08% H: 0.33% C: -0.53%
ARTL | $1.28 -1.94% 5.5K

|

Health Technology

| -13.82% | O: -4.61% H: 4.83% C: 3.84%
business update financial results

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RXO P 200000 | $19.37 2.32% 0.0% 1M

|

| 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA P 2750 | $0.377 -1.4% 97K

|

Health Technology

| 22:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar